期刊文献+

脑胶质瘤病22例临床观察和分析 被引量:10

下载PDF
导出
摘要 目的:探讨脑胶质瘤病的临床特征及预后分析。方法:收集1995年1月至2009年12月收治的22例脑胶质瘤的病例资料,回顾性分析临床特征、治疗情况及预后情况。结果:本组男13例,女9例,性别比例1.4∶1。年龄19~65岁,中位年龄43岁。KPS评分50~90分,中位评分80分。主要临床症状为头痛18例,肢体乏力14例,言语不清7例,癫痫发作5例,智力减退2例,偏瘫1例。中位生存期19个月,2年的生存率为67.9%。单因素预后分析中性别、年龄、KPS评分、分型、病理类型不是总生存的独立预后因素。高级别胶质瘤中位生存期9个月,低级别22个月(χ2=8.780,P=0.003),病理分级为独立预后因素。结论:脑胶质瘤病罕见,男性、中年人中发病率较高,多无特异性临床表现,单因素预后分析病理分级为独立预后因素。
出处 《实用医学杂志》 CAS 北大核心 2012年第15期2570-2572,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献14

  • 1Nevin S. Gliomatosis eerebri [J]. Brain, 1938,61:170-191.
  • 2Park S, Suh Y L, Nam D H, et al. Gliomatosis cerebri: clinicopathologic study of 33 cages and comparison of mass forming and diffuse types [J]. Clin Neuropathol, 2009,28(2): 73-82.
  • 3Kleihues P, Louis D N, Scheithauer B W, et al. The WHO classification of tumors of the nervous systeem [J]. J Neuropathol Exp Neurol, 2002,61 (3) : 215-229.
  • 4Sanson M, Napolitano M, Cartalat-Carel S, et al. Gliomatosis cerebri [J]. Rev Neurol (Paris), 2005,161(2): 173-181.
  • 5Park S, Suh Y L, Nam D H, et al. Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse types [J]. Clin Neuropathol, 2009,28(2): 73-82.
  • 6Louis D N, Ohgaki H, Wiestler O D, et al. The 2007 WHO classification of tumours of the central nervous system [J]. Acta NeuropathoI, 2007,114 (2) : 97-109.
  • 7Taillibert S, Chodkiewicz C, Laigle-Donadey F, et al. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature [J]. J Neurooncol, 2006,76(2): 201-205.
  • 8钱海蓉,戚晓昆,王巍,刘建国,刘鹏,邱峰.经病理证实的大脑胶质瘤病的临床及影像特点[J].中华神经科杂志,2010,43(12):847-852. 被引量:9
  • 9Romeike B F, Mawrin C. Gliomatosis cerebri: growing evidence for diffuse gliomas with wide invasion [J]. Expert Rev Neurother, 2008,8(4) :587-597.
  • 10张华楸,舒凯,叶飞,郭东升,牛洪泉,雷霆,李龄.脑胶质瘤病的诊断和治疗[J].中华神经医学杂志,2005,4(6):582-584. 被引量:10

二级参考文献25

  • 1潘初,朱文珍,黄博,夏黎明,漆剑频,王承缘.脑胶质瘤病的MRI及MRS研究[J].放射学实践,2004,19(9):631-634. 被引量:6
  • 2Louis DN,Ohgaki H,Wiestler OD,et al.The 2007 WHO classification of tumors of the central nervous system.Acta Neuropathol(Berl),2007,114:97-109.
  • 3Taillibert S,Chodkiewicz C,Laigle-Donadey F,et al.Gliomatosis cerebri:a review of 296 cases from the ANOCEF database and the literature.J Neurooncol,2006,76:201-205.
  • 4Sanson M,Napolitano M,Cartalat-Carel S,et al.Gliomatosis cerebri.Rev Neurol(Paris),2005,161:173-181.
  • 5San Millan B,Kaci R,Polivka M,et al.Gliomatosis cerebri:a biopsy and autopsy case report.Ann Pathol,2010,30:25-29.
  • 6Ghostine S,Raghavan R,Michelson D,et al.Gliomatosis cerebri mimicking Rasmussen encephalitis.Case report.J Neurosurg,2007,107:143-146.
  • 7Duron E,Lazareth A,Gaubert JY,et al.Gliomatosis cerebri presenting as rapidly progressive dementia and parkinsonism in an elderly woman:a case report.J Med Case Reports,2008,20:53.
  • 8Masuoka J,Tabuchi K.Gliomatosis cerebri.Nippon Rinsho,2005,63:128-132.
  • 9Park S,Suh YL,Nam DH,et al.Gliomatosis cerebri:clinicopathologic study of 33 cases and comparison of mass forming and diffuse types.Clin Neuropathol,2009,28:73-82.
  • 10Rizzo L,Crasto SG,Moruno PG,et al.Role of diffusion-and perfusion-weighted MR imaging for brain tumor characterization.J Radiol Med,2009,114:645-659.

共引文献17

同被引文献67

  • 1孙建军,王振宇.恶性脑胶质瘤的局部治疗进展[J].中华医学杂志,2005,85(20):1438-1439. 被引量:16
  • 2Miranda Goncalves V, Honavar M, Pinheiro C, et al. Mono- carbox-ylate transporters (MCTs) in gliomas= expression and exploitationas therapeutic targets. Neuro Oncol, 2013,15 (2) : 172- 188.
  • 3Dixit D,Sharma V, Ghosh S, et al. Inhibition of Casein kinase -2 induces p 53-dependent cell cycle arrest and sensitizes glio- blastoma ceils to tumor necrosis factor (TNFa)-induced apop- tosis through SIRT1 inhibition[J]. Cell Death Dis, 2012,9(3) : 271.
  • 4Halestrap AP. The SLC16 gene family-structure, role and regulation in health and disease. Mol Aspects Med, 2013, 34 (2-3) : 337-349.
  • 5De Saedeleer CJ, Copetti T, Porporato PE, et al. Lactate acti- vatesHiF-1 in oxidative but not in Warburg-phenotype human tumorcells. PLoSOne, 2012, 7(10): e46 -571.
  • 6Nima-Etminan D. Corinna-Peters SC ,Ficnar J,et al. Modula tion of migratory activity and invasiveness of human glioma spheroids following S-aminolevulinic acid based photodynamic treatment [J]. Neurosurgery,2011,115(2) :281 -288.
  • 7Hisaoka K, Tsuchioka M, Yano R ,et al. Tricyclic antide- pressant amitriptyline Activates fibroblast growth factor re- ceptor signaling in glial cells: involvement in glial cell lined erived neuro trophic factor production [J]. BidChem, 2011, 286(10) :21 118 -21 108.
  • 8Chen Y,Tsai YH, Tseng SH. Valproic acid affected the sur vival and invasiveness of human glioma cells through diverse mechanisms[J], ournal of Neuro- Ontology, 2012,109 ( 1 ) : 23-33.
  • 9Badiga AV, Cherty C, Kesanakurti D, et al. MMP-2 siRNA Inhibits Radiation Enhanced Invasiveness in Glioma Cells[J]. PLoS One,2011,6(6) :20- 614.
  • 10郗金锁.脑部神经胶质瘤的常见类型及MRI表现[J].实用医技杂志,2007,14(34):4680-4680. 被引量:2

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部